Laser manufacturer Sciton has entered into a strategic partnership with Michelson Diagnostics, Ltd. (MDL), maker of the VivoSight OCT (Optical Coherence Tomography), to develop OCT image-guided laser applications for its devices.
Several physicians are excited about the potential of OTC in ablative laser treatments. “OCT will be the greatest addition to the laser clinician's armamentarium against scars since fractional ablative lasers,” said Jill Waibel, MD, medical director of the Miami Dermatology and Laser Institute. “The depth of the scar can be accurately visualized and treatment can be tailored accordingly. As OCT also clearly images blood vessel size and location, stubborn vascular lesions are characterized better for better clearance results.”